FDA Inspection 1165318 — Thomas Scott Jones
The FDA completed an inspection of Thomas Scott Jones on Mar 9, 2022 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 9, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- San Antonio, TX (United States)
Additional details
Clinical Investigator (CI)